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a b s t r a c t
The mechanisms regulating cell division during development of the mouse pre-implantation embryo are
poorly understood. We have investigated whether bone morphogenetic protein (BMP) signaling is
involved in controlling cell cycle during mouse pre-implantation development. We mapped and
quantitated the dynamic activities of BMP signaling through high-resolution immunofluorescence
imaging combined with a 3D segmentation method. Immunostaining for phosphorylated Smad1/5/8
shows that BMP signaling is activated in mouse embryos as early as the 4-cell stage, and becomes
spatially restricted by late blastocyst stage. Perturbation of BMP signaling in preimplantation mouse
embryos, whether by treatment with a small molecule inhibitor, with Noggin protein, or by over-
expression of a dominant-negative BMP receptor, indicates that BMPs regulate cell cleavage up to the
morula stage. These results indicate that BMP signaling is active during mouse pre-implantation
development and is required for cell cleavage in preimplantation mouse embryos.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Mammalian pre-implantation development has been best stu-
died in the mouse. After fertilization, mammalian embryos
undergo four rounds of cell division to reach the morula stage, a
solid ball of approximately 16 cells. Cells on the inside of the
morula differ from those on the outside in several ways including
genes expressed, cell shape, and cell adhesion characteristics
(Ziomek et al., 1982; Zernicka-Goetz et al., 2009; Rossant and
Tam, 2009). Subsequently, a combination of symmetric and
asymmetric cell divisions and cavitation transforms the morula
into a blastocyst (32-cell stage) (Smith and McLaren, 1977). The
blastocyst hatches from the zona pellucida in preparation for
implantation at around embryonic day E 4.5.
Inner cell mass (ICM) and trophectoderm (TE) cell differentia-
tion is promoted by several transcription factors (TFs) that are
expressed dynamically during this developmental transition.
Pou5f1/Oct4, Nanog, and Sox2 specify ICM cells while Tead4 and
Cdx2 specify TE cells (Nichols et al., 1998; Avilion et al., 2003;
Chambers et al., 2003; Strumpf et al., 2005; Wang and Dey, 2006;
Yagi et al., 2007; Nishioka et al., 2008). TE cells can be further
characterized by their location relative to the ICM as polar and
mural TE cells. Polar TE cells are defined as those that overlay the
ICM while the mural TE cells overlay the blastocoel cavity, with
division of polar TE contributing cells to the mural TE compart-
ment (Copp, 1978; Gardner and Davies, 2002). The essential roles
of TFs such as Pou5f1/Oct4, Nanog, Sox2, Tead4 and Cdx2 in
specifying ICM and TE lineages have been extensively studied.
In contrast, our understanding of how cell division is regula-
ted during pre-implantation development is relatively limited
(Ciemerych and Sicinski, 2005).
Recent single cell RNA-seq expression profiling (Tang et al.,
2010) indicates BMP signaling components, including BMP ligands,
receptors, and Smads, are all expressed in early stages of mouse
pre-implantation development (Fig. S1). This raises the possibility
that BMP signaling may function during mouse pre-implantation
development. Mouse mutants deficient in various BMP ligands,
intracellular transducers, and receptors have underscored the
importance of BMP signaling during gastrulation; e.g. Mishina
et al. (1995), Macías-Silva et al. (1998), Solloway and Robertson
(1999), Yi Se et al. (2009), Arnold et al. (2006), but has thus far failed
to disclose a role(s) for BMP signaling at pre-implantation stages,
possibly because of redundancies in BMP signaling that ensure the
robustness of embryonic developmental programs. Smad1 and
5 single homozygous null mice have similar phenotypes as the
Smad1þ /: Smad5þ / double heterozygous mutants presumably
because they are functionally redundant (Arnold et al., 2006). An
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inability to generate Smad1 and 5 homozygous null mice precluded
genetic analysis of a role for BMP signaling in pre-implantation
mouse development, illustrating the challenge of investigating the
function of BMP signaling pathway components in development.
Mice deficient in BMP type I receptor (BMPr1a/ALK3) or type II
receptor (BMPrII/BMPR2), however, were smaller and had fewer
cells (Beppu et al. 2000; Mishina et al. 1995), supporting a potential
involvement of BMP signaling in cell proliferation. Coucouvanis and
Martin (1999) used in situ hybridization to demonstrate that Bmp4
RNA is present exclusively in the ICM cells of the blastocyst. They
also used in vitro culture of embryoid bodies made from aggregated
PSA1 embryonal carcinoma cells to demonstrate that inhibition of
BMP via expression of a dominant negative Bmpr-Ib blocked both
cavitation and expression of Hnf4a, a marker of visceral endoderm.
To investigate if BMP signaling functions in mouse preimplan-
tation embryonic development, we measured the direct output of
BMP signaling during this period using two different approaches.
The first method examines the transcriptional response of “BMP-
indicator” mouse embryos, while the second measured the status
of Smad1/5/8 phosphorylation within preimplantation stage
embryos. We mapped and quantitated the dynamic activities of
BMP signaling through high-resolution immunofluorescence ima-
ging combined with a 3D segmentation method. We find that BMP
signaling activity can be detected in all blastomeres as early as the
4-cell stage (E2.0) and becomes spatially restricted by late
blastocyst stage. Perturbation of BMP signaling in embryos, by
treatment with a pharmacologic inhibitor, by Noggin protein, or by
overexpression of a dominant-negative BMP receptor, each del-
ayed cell cleavage during early cleavage stages. Based on these
results, we propose that BMP signaling is required for normal cell
cycle during development of the preimplantation mouse embryo.
Results
BMP signaling activity in preimplantation embryos revealed by BRE-
gal expression and the phosphorylation state of Smad1/5/8
We investigated for evidence of BMP activity during mouse pre-
implantation development using mice transgenic for a BMP-
dependent lacZ reporter gene (BRE-gal) (Javier et al., 2012). BMP-
responsive elements (BRE) are cis-acting sequences that respond to
canonical Smad-dependent BMP signaling in the frog Xenopus (von
Bubnoff et al., 2005), Drosophila (Yao et al., 2006), zebrafish (Alexander
et al., 2011), and mouse (Javier et al., 2012; Doan et al., 2012). A BRE
element was adapted to generate a BMP-dependent reporter gene by
placing seven copies of the BRE in tandem upstream of a X. laevis Id3-
gene minimal promoter:: nlsLacZ reporter gene (Maretto et al., 2003).
BRE-gal mice identified SMAD-dependent BMP activity in E5.5 to
E13.5 post-implantation stage mouse embryos (Javier et al., 2012;
Doan et al., 2012). We used BRE-gal mice to analyze BMP signaling in
the pre-implantation mouse embryo from morula (E2.5) to blas-
tocyst (E3.5) stage (Fig. 1A). Nuclear β-gal activity was observed in
both ICM and TE of blastocysts, although the activity in ICM was in
general stronger than that observed in TE. To provide independent
evidence that BMP signaling is active in the blastocyst, immunofluor-
escence analysis was performed to identify the phosphorylated form
of Smad1/5/8 (hereafter referred to as p-Smad1), produced by
receptor-activated BMP signaling. Phospho-Smad1 was detected in
all nuclei of the E3.5 stage embryo (Fig. 1B). The difference in cellular
patterns of X-gal staining (enriched expression in ICM) and p-Smad1
immunostaining (uniform expression) may be due to reduced sensi-
tivity of the BRE-gal reporter compared to anti-pSmad1 staining.
Alternatively, although both ICM and TE cells receive BMP signaling,
the transcriptional machinery mediating BMP signaling in these
lineages may differ, with only a subset of this activity being detected
by the BRE-gal reporter construct. Immunostaining using a pan-
Smad1 antibody showed predominantly cytoplasmic localization of
Smad1 (Fig. 1C) suggesting that the majority of Smad1 present in the
preimplantation stage embryos is unphosphorylated. This suggests
that the availability of Smad1 is not rate limiting in regulating BMP
signaling activity in the preimplantation stage mouse embryo.
Specificity of the p-Smad1 antibody was verified using E14Tg2a
mouse embryonic stem (mES) cells. Following stimulation with
BMP4 the mES cells show p-Smad1 staining within the nucleus,
which was inhibited in the presence of either Noggin or a small
molecule BMP antagonist LDN193189 (4-(6-(4-(piperazin-1-yl)phe-
nyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline hydrochloride) (Fig. S2A;
Vogt et al., 2011). X-gal staining of BRE-gal ES cells also shows that
BRE-gal induction was dependent on BMP signaling (Fig. S2B).
Western blot analysis of total protein from treated mES cells also
detected p-Smad1 upon stimulation with BMP4, which was pre-
vented in the presence of LDN193189 (Fig. S2C). LDN193189 is a
highly selective antagonist of the intracellular kinase domain of the
BMP receptor isotypes ALK2 (activin receptor-like kinase 2, also
known as ACVR1), ALK3 (BMPR1A) and ALK6 (BMPR1B) (Yu et al.,
2008; Cuny et al., 2008). We also examined the effect of LDN193189
on the transcriptional response of known BMP-target genes and
found that the inhibitor effectively down-regulated expression of Id1,
Id2 and Id3 (Hollnagel et al., 1999) (Fig. S2D). Taken together, our data
support that p-Smad1 staining in E3.5 mouse blastocysts is specific
and that LDN193189 is an effective BMP antagonist.
BMP signaling is detected as early as the four-cell stage of mouse
development
We determined the earliest stage at which p-Smad1 staining is
detectable in preimplantation stage mouse embryos. Phospho-
Smad1 staining is below the limit of detection in the 2-cell stage
embryo, but is detected at the 4-cell stage and persists through late
blastocyst (100-cell stage) (Fig. 1D and E). The onset of p-Smad1
staining precedes the appearance of X-gal staining in the BRE-gal
embryos, the latter first being detected at around the 16-cell morula
stage (Fig. 1A). The observed delay in X-gal staining (Fig. 1A) could
be explained by a required threshold concentration of p-Smad1 to
activate the BRE-gal reporter gene or that the BRE-gal reporter is
not responsive to all BMP signaling events. Based on these results,
we conclude that BMP signaling is activated by the 4-cell stage,
prior to known activation of transcription factors including Cdx2,
Nanog, Tead4 and Pou5f1/Oct4 that are required to establish the
transcriptional network for ICM and TE cell lineage selections
(Nichols et al., 1998; Avilion et al., 2003; Chambers et al., 2003).
Confocal imaging (Fig. 1F) revealed a non-uniform, punctate
staining of p-Smad1 predominantly within the nucleus, but absent
from the nucleolus. Nucleoli were identified by absence of Hoechst
staining within the nucleus (Martin et al., 2005). This punctate
staining can be detected as early as 4-cell stage (E2.0) and
persists until the blastocyst stage (E3.5–4.5). Similar punctate
p-Smad1-staining pattern has been observed in other tissues
(Eom et al., 2011; Hogg et al., 2010), and may represent transcrip-
tional regulatory complexes.
Increased p-Smad1 in the ICM
We investigated whether average cellular phospho-Smad1 levels
changed during early pre-implantation development. To quantitate
changes we developed a computer program that segments individual
nuclei in three-dimensional confocal stacks (a sample output of an
analysis is shown in Fig. 2A, and volume rendering of an embryo in
Fig. 2B; see “Experimental procedures” section for more detail and
accuracy measurements, Fig. S3A). Mean p-Smad1 levels at the four
and eight cell stages were not significantly different (p¼0.16).
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Likewise, mean p-Smad1 levels remained constant at the 16, 32, and
64-cell stages (Fig. 2C, S3B and C).
Next, we asked whether p-Smad1 levels differed in inner cells
versus outer cells. To address this question we quantified p-Smad1
levels in manually annotated inner and outer cells using image
segmentation (see the “Experimental procedures” section). No
significant difference was observed in 16-cell stage embryos
(Fig. 2D left, p¼0.2, n¼18, Fig. S3C). In contrast, p-Smad1 levels
were enriched in ICM cells at the 64-cell stage blastocyst (Fig. 2D
right, po0.001, n¼13, Fig. S3C). We also compared p-Smad1 levels
in manually annotated polar/mural TE cells, using the embryonic
axis and ICM to distinguish the two cell types. At the 64-cell stage,
polar TE cells had higher p-Smad1 levels than mural TE cells
(Figs. 2E, po0.001; see Fig. 2F for spatial distribution of p-Smad1
in a sample embryo). The observation that ICM cells displayed
more intense p-Smad1 staining than TE cells (Fig. 2D, E and
Fig. S3D) and that BMP4 was specifically expressed in the ICM
cells (Fig. S1), combined with a study of the mitotic index of
different regions of the TE (Copp, 1978), suggests secretion of
BMP4 from the ICM may influence the mitotic index of TE cells
with proximity to a higher local concentration of BMP correlating
with higher mitotic index in polar TE versus mural TE.
BMP signaling in cell division
To investigate functions of BMP signaling during pre-implan-
tation development, BMP signaling was inhibited using the small
molecule BMP antagonist LDN193189. Culture of 8-cell stage emb-
ryos in 1 mM LDN193189 for 24 h blocked formation of a blasto-
coel cavity (Fig. 3A). We verified LDN193189 was blocking BMP
signaling with p-Smad1 immunostaining, which was weaker
in LDN193189-treated embryos (Fig. 3B, top panels). Similarly,
BRE-gal reporter gene activity was also reduced in morula stage
embryos treated with LDN193189 (Fig. 3B, bottom panels). We
quantified p-Smad1 levels in LDN193189-treated embryos (n¼8,
30-cells per embryo) and in sibling control embryos (n¼5, 54-
cells per embryo) using image segmentation (see the “Experi-
mental procedures” section). Mean p-Smad1 levels were reduced
in LDN193189-treated embryos (Fig. 3C, po0.001).
Fig. 1. Bre-gal reporter activity and location of p-Smad1 in preimplantation mouse embryos. (A) Homozygous BRE-gal and CD1 E3.5 mouse embryos (8-cell, morula, and
blastocyst stage) stained for β-gal activity using X-gal. X-gal staining is stronger in the ICM compared to the TE of mouse blastocysts. Non-transgenic (wild type) embryos do
not show X-gal staining. (B and C) E3.5 mouse embryos immunostained with p-Smad1 and Smad1 antibodies, respectively. (D and E) Timeline of p-Smad1 activity in
developing mouse embryos between E1.5 and E4.5 stages (2–100-cell stages). (F) Nuclei of E2.5-E4.5 mouse embryos stained for p-Smad1 and DNA, nucleoli lacking pSmad1
are indicated by white dotted circles. Scale bar¼100 mm.
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Fig. 2. Distribution of p-Smad1 in preimplantation embryos. (A) Schematic of data acquisition. Z-stacks of each randomly oriented embryo were collected using 63
objective at 0.3 mm intervals, and subjected to a 3D segmentation approach. DNA in blue (left), segmented nuclei in yellow (middle), and merged image (right). (B) A 3D
image of an embryo after segmentation and a magnified nucleus. (C) Nuclear p-Smad1 concentrations in the blastomeres of pre-morula (4–8-cell) and later stage embryos
(16-, 32-, and 64-cell). (D) Distribution of nuclear p-Smad1 concentrations at 16-, 32- and 64-cell stages. p-Smad1 concentrations in inside and outside cells of 16-cell stage
embryos are 0.43 and 0.46, respectively. p-Smad1 concentrations in ICM and TE cells of 32-cell stage blastocysts are 0.47 and 0.45, respectively. p-Smad1 concentrations of
ICM cells of 64-cell stage embryos (0.49, n¼314 cells) are notably higher than those in TE cells (0.38, n¼485 cells, po0.001). (E) p-Smad1 staining levels in ICM (n¼104
cells), Polar TE (n¼142 cells), and Mural TE (n¼213 cells) in 100-cell stage embryos. (ICM vs Polar TE, po0.001; ICM v Mural TE, po0.001; Polar vs Mural TE, po0.001).
(F) Nuclear p-Smad1 concentration in individual nuclei; ICM is located at the bottom of the embryo shown. Florescence intensity differences were color-coded on
segmentation outlines (from low to high: purple, orange, yellow and white). The numerical numbers from 0 to 1 indicate the relative fluorescence intensity range. p-values
were derived using Student’s t-test.
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LDN193189-treated embryos had fewer cells compared to
in vitro-cultured control embryos (Fig. 3D, po0.001). Two criteria
suggest the reduction in cell number after LDN193189-treatment
is not due to increased cell death. The first is absence of DNA
condensation and nuclear fragmentation, characteristics of apop-
tosis (White, 1996), in DNA stained embryos treated with 1 mM
LDN193189. Second, apoptosis was not detected in embryos
treated with 1 mM LDN193189 (n¼16) using a TUNEL assay,
although at a higher concentration of LDN193189 (2.5 mM), apop-
tosis could be detected (Fig. S4). These results suggest that
inhibition of BMP signaling by 1 mM LDN193189 interferes with
normal blastocyst development by reducing mitotic index and not
by increasing rate of apoptosis.
We next investigated whether pre-implantation embryos dis-
played stage-specific sensitivity to LDN193189-mediated inhibi-
tion of BMP signaling. Pre-implantation embryos were isolated at
different stages (E2.5, E3.0, and E3.5), then cultured in vitro for 24
hours in the presence of 1 mM LDN193189 (Fig. 4A). Over 50% of
8-cell embryos (“early morula”) cultured in this manner failed to
form normal blastocysts (Fig. 4Bb and Bb0), while late morula and
blastocyst stage embryos treated with LDN193189 formed mor-
phologically normal blastocysts (Fig. 4B and C). These results
identify an important BMP signaling period in 8-cell early embryos
and indicate that exposure to 1 mM LDN193189 does not cause
death of the embryo. We further determined that LDN193189
treatment for as little as 12 h was sufficient to affect cell cleavage
(Fig. S5A). Embryos treated with lower LDN193189 concentrations
(0.25 mM) displayed similar, albeit weaker, effects (Fig. S5B). We
also cultured LDN193189-treated embryos beyond 24 h. While
some embryos failed to develop further, the surviving embryos
were able to form blastocysts at later stages, suggesting that BMP
signaling inhibition causes developmental delay.
Overexpression of a dominant negative BMP receptor blocks cell
cleavage
One concern of using chemical inhibitors is possible non-specific
effects of the drug—in this case, inhibition of other ALK family
receptors. To obtain independent evidence for a function of BMP
signaling in early embryonic cell cleavage, we used a genetic
approach. A DNA construct (CMV-DNBR-HA) encoding an epitope-
tagged dominant negative type I BMP receptor 1a (BMPR1a/ALK3)
was generated (Lim et al., 2004). The ability of this construct to affect
BMP signaling was tested in mES cells. As with LDN193189 treat-
ment, expression of CMV-DNBR-HA inhibited phosphorylation of
Smad1 upon BMP4 stimulation, (Fig. S6A, lanes 3, 4). To examine the
effects of expressing DNBR-HA in embryos, we microinjected CMV-
DNBR-HA into a single blastomere of 2-cell stage embryos and
analyzed the effect at the 8-cell stage of development (Fig. 5A). The
presence of DNBR-HA on the surface membrane of the descen-
dants of injected blastomeres was confirmed by immunostaining
(Fig. S6B). The cell number in CMV-DNBR-HA/CMV-β-gal co-injected
and control CMV-β-gal injected embryos were quantified after 24 h
of in vitro culture. Embryos expressing CMV-DNBR-HA/CMV-β-gal
had an average of 6.4570.2 cells, while CMV-β-gal injected
embryos had 8.270.4 cells. Thus, DNBR-HA expressing embryos
have fewer cells than control CMV-β-gal injected embryos (Fig. 5B
and C; po0.001), and reduced levels of p-Smad1 staining (Fig. S6C;
po0.001). Cell lineage analysis (β-gal expressing cells) also revealed
that fewer cells were derived from CMV-DNBR-HA-expressing blas-
Fig. 3. BMP signaling inhibition affects cell cleavage. (A) Images of embryos collected at E2.5 (pre-compaction, top panels) and incubated with and without LDN193189 for
24 h (bottom panels). (B) Decrease in p-Smad1 and X-gal staining in embryos cultured in LDN193189 for 24 h. Scale¼100 mm. (C) Quantification of p-Smad1 in control (n¼5,
mean concentration of 0.66) and LDN193189-treated (n¼8, mean concentration of 0.40, po0.001) embryos. The data is reported as nuclear concentration. (D) Decrease in
cell numbers in embryos treated with LDN193189. The average numbers of cells are 5172.5 cells for control (n¼33) and 30.672 cells at 1 mM LDN193189 (n¼38, po0.001).
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tomeres (an average of 2.570.1 cells) compared to those contrib-
uted from the uninjected control blastomere (contralateral side,
3.770.2 cells). We used an additional independent method to
inhibit BMP signaling in pre-implantation embryos, by removing
the zona pellucida using acid Tyrode’s followed by incubation of the
8-cell stage embryos with Noggin protein, a BMP antagonist. Noggin
treatment also resulted in developmental delays (Fig. 6D). These
results provide independent confirmation that inhibition of BMP
signaling affects cell cleavage in preimplantation stage embryos.
Time lapse imaging of LDN193189-treated embryos
To better define the cell cleavage defects seen in mouse
embryos after the LDN193189 treatment, we performed time-
lapse imaging of CAG:H2B-GFP mouse embryos that express GFP
tagged histone H2B in the presence and absence of LDN193189
(Kurotaki et al., 2007). Fig. 5E shows the images of CAG:H2B-GFP
e1.5 embryos (2-cell stage) after 60 h of in vitro culturing with and
without LDN193189. LDN193189-treated embryos (bottom panel)
develop significantly slower than the untreated embryos (top
panel). We quantified the average cell-cycle time of each cleavage,
and found that 2nd, 3rd, 4th and 5th cleavages are all significan-
tly delayed in LDN193189-treated embryos (Fig. 5F). Throughout
this experiment, no evidence of apoptosis was detected. Hence,
LDN193189-treatment appears to cause an increase in cell cycle
time without causing apoptosis.
Inhibition of BMP signaling delays ICM and TE cell segregation
We hypothesized that if BMP signaling is required for blasto-
cyst formation, blockade of BMP signaling by LDN193189 might
disrupt ICM and TE cell lineage specification. Nanog and Cdx2
positive cells are present in the morula stage embryo, and by the
early blastocyst stage they segregate to mark ICM and TE cells
(Dietrich and Hiiragi, 2007). We examined whether inhibiting BMP
signaling via LDN193189 alters Nanog and/or Cdx2 expression.
Embryos at 8-cell stage were treated with 1 mM LDN193189,
cultured in vitro for 24 h, and subjected to immunofluorescence
staining for the transcription factors Nanog and Cdx2 followed by
3D segmentation (Fig. 6A). As noted previously, LDN193189
treated embryos showed delay in cell cleavage (Fig. 6B). Exposure
to LDN193189 caused reduction of Cdx2 in outside cells, while
Nanog expression was relatively unaffected (Fig. 6C and D). To
determine whether the difference in Cdx2 expression could be a
consequence of developmental delay, we compared the expression
of Nanog and Cdx2 to that found in cell number matched embryos
(30-cell stage embryo, 12 h control). The relative expression
levels of Nanog and Cdx2 were similar suggesting that the
difference in gene expression between control and LDN193189-
treated embryos is due to developmental delay.
Discussion
We have examined the presence of BMP signaling during
development of the preimplantation stage mouse embryo and
investigated its function during this process. The results indicate
that BMP signaling is active as early as the 4-cell stage of
development and is required to regulate rate of cell cleavage up
to the morula stage.
Results of experiments using three independent methods
provide consistent support for the requirement of BMP signaling
during pre-implantation development. Inhibition of BMP signaling
by LDN193189 using concentrations up to 1 mM interferes with cell
cleavage, but does not cause cell death. Expression of a dominant
negative BMPR1a/ALK3 in mosaic embryos, and exposure of whole
embryos to the BMP-antagonist Noggin cause similar effects on
rate of cell division. Based on these findings we postulate that
inhibition of BMP signaling via ALK3 reduces cell number in the
blastocyst by increasing cell cycle length. How might BMP signal-
ing influence rate of cell division? BMP signaling can directly
control expression of Id genes, which encode proteins that heter-
odimerize with basic helix-loop-helix (bHLH) proteins thereby
inhibiting their function. Basic HLH proteins have been implicated
in regulation of the cell cycle (von Bubnoff et al., 2005; Massari
and Murre, 2000; Murre et al., 1989). Id2 and Id3 are differentially
expressed in preimplantation stage embryos (Tang et al., 2010;
Guo et al., 2010) and forced expression of Id genes can bypass the
mES cells requirement for BMP for self-renewal (Ying et al., 2003).
Hence, regulation of the cell cleavage by BMP signaling might be
mediated via differential expression of Id2 and Id3.
Interestingly, BMP signaling can also negatively regulate cell
division in the early mouse embryo. Epiblast specific loss of
ACVR1/ALK2 affects the ability of ventral cells in the node to enter
G0 (Komatsu et al., 2011). Deletion of ALK2 attenuated the level of
stabilized p27Kip1 cyclin-dependent kinase inhibitor normally
required to inhibit nodal cell proliferation and formation of a
primary cilium. Together with the results of the present study, this
suggests BMP signaling can have opposite effects on cell cycle in
the early mouse embryo depending on the specific BMP signaling
pathway and cell type involved.
Signaling through BMP receptors can be transduced via Smad4-
dependent canonical (Smad1/5/8) pathways and Smad4-independent
Fig. 4. Temporal limits of LDN193189 sensitivity. Experimental schematic deter-
mining the BMP signaling sensitive period. (B) Embryos at early morula (uncom-
pacted), late morula (compacted), early blastocyst (32-cell) and late blastocyst
(60-cell) stages before (a–h) and 24 h after LDN193189 treatments (a0–h0).
(C) Percentages of embryos reaching blastocysts stage (a and a0) n¼37, (b and b0)
n¼52, (c and c0) n¼72, (d and d0) n¼60, (e and e0) n¼14, (f and f0) n¼13, (g and g0)
n¼48, (h and h0) n¼46). *po0.05 based on Student’s t test.
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non-canonical (BMP/TGF-β-activated kinase-1, TAK1) pathway
Yamaguchi et al., 1999, 1995; Derynck and Zhang, 2003; Moustakas
and Heldin, 2005). At present, the relative contribution of these
pathways to cell division in preimplantation embryos is not fully
understood. Mutation of Smad4 in mice results in defective gastrula-
tion (Takaku et al., 1998; Chu et al., 2004) although analysis of embryos
at preimplantation stages was not reported in these studies. It would
be of interest to investigate if Smad4-mutant pre-implantation
embryos have fewer cells compared to control embryos. BMP signaling
might also influence cell division via the TAK1 non-canonical signaling
pathway. Smad1 activity can be inhibited by phosphorylation of its
linker region by ERK, which results in exclusion of Smad1 from the
nucleus (Kretzschmar et al., 1997) and its association with Smurf1
which ubiquitinylates Smad1 leading to its degradation (Fuentealba
et al., 2007; Sapkota et al., 2007). TAK1 can maintain Smad1 activity
indirectly by inhibiting ERK. The mechanism of inhibition involves
p38-dependent activation of a PP2A complex that binds and depho-
sphorylates MEK and ERK (Westermarck et al., 2001). Interestingly,
pre-implantation mouse embryos express all four genetic forms of p38
(α,β,δ,γ) and pharmacologic inhibition of p38 α and β forms can
reversibly halt mouse embryo development at the 8–16 cell stage but
not before (Natale et al., 2004). Hence, BMP signaling, in part via TAK1,
might be required for cell division of mouse embryos following
compaction.
BRE-gal ES cells respond well to exogenous BMP stimulation as
indicated by strong β-gal activity (Fig. S2B). However, BRE-gal mES
Fig. 5. Dominant-negative BMP receptor overexpression affects cell cleavage. (A) Schematic diagram showing DNA microinjection experiment. (B) Effects of DNBR-HA
expression on cell cleavage. CMV-βgal injected embryos with and without CMV-DNBR-HA were subjected to X-gal staining. Dark grey colored blastomeres in X-gal panels
indicate the descendants of CMV-β-gal injected blastomeres. Scale bar¼100 mm. (C) Bar graph showing the effects of DNBR-HA on cell cleavage. Average total cell numbers
per embryos after pCMVβ and pCMVβ/DNBR-HA injections are 8.470.4 cells and 6.4570.2 cells, respectively. The number of X-gal lineage traced blastomeres for pCMVβ
and pCMVβ/DNBR-HA are 3.770.2 cells and 2.570.1 cells, respectively. For pCMVβ (n¼27) and for pCMVβ/DNBR-HA (n¼40). (D) Decrease in total cell numbers after Noggin
treatment. Total cell numbers after each Noggin treatment are 62.571.5 cells (n¼3, control), 53.175.7 cells (n¼7, 1 ng/ml), 39.174.1 cells (n¼8, 10 ng/ml), and 37.876.3
cells (n¼9, 50 ng/ml). (E) Images of H2BeGPF with and without LDN193189. (F) LDN193189 treatment delays cell cleavage. Cell cleavage lengths were measured for control
(n¼14) and LDN treated (n¼19) embryos at the 2nd, 3rd, 4th, and 5th, cleavage. *po0.05, **po0.001, BF, bright field. Data are averages 7SEM.
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cells do not respond to endogenous levels of BMPs present in
serum under in vitro culture condition. We postulate this is
because BRE-gal mES cells respond to moderate levels of BMP
signaling and the amount of BMP signaling present in in vitro
culture condition is insufficient to provide strong β-gal activity.
Alternatively, exposure to serum stimulates pathways that inhibit
BMP signaling intracellularly. Consistent with this notion, weak β-
gal activity was observed when BRE-gal mES cells were incubated
in X-gal substrate for a longer period of time. Additionally, in the
monolayer of BRE-gal mES cells, we observed patches of cells
showing stronger β-gal activity (Fig. S2B, serum control). These X-
gal positive ES cells may represent ES cells responding to high
concentrations of local BMP signaling influenced by neighboring
cells. In that light, it is interesting to note that X-gal staining of
mouse morula stage embryos is significantly stronger than that of
in vitro cultured BRE-gal ES cells, suggesting that the endogenous
level of BMP activity present in mouse morula stage and blasto-
cysts is relatively high.
The available expression data for BMP signaling components
during mammalian development suggests that qualitatively differ-
ent BMP signaling may occur across preimplantation stages. Both
Tang et al. (2010) and Wicher et al. (personal communication) obs-
erved that the inner and outer cells of morula-stage mouse embryos
display differential expression of BMP ligands and receptors. BMP6
and BMP7 are expressed early and their expression declines quickly
after fertilization, while BMP4 expression becomes enriched in the
ICM of developing blastocysts (Coucouvanis and Martin, 1999;
Fig. S1). BMP receptor 1a (Bmpr1a/ALK3) and 1b (Bmpr1b/ALK6)
Fig. 6. BMP signaling inhibition delays blastocyst development. (A) Embryos isolated at E2.5 were cultured in vitro with and without LDN193189 for 24 h and stained for
Nanog and Cdx2 (top and middle). Cell number-matched control embryos cultured for 12 h (right). (B) The average total cell number of LDN193189 treated embryos (30
cells per embryo, n¼12) is significantly reduced when compared to the embryos cultured for 24 h (60 cells per embryo, n¼4), but is comparable to the 12 h cultured
embryos (30 cells per embryo, n¼8). (C and D) Scatter plots and box- whisker plots of Nanog and Cdx2 concentrations in individual blastomeres (inside black and outside
red) blastomeres. Blastomeres of LDN193189 treated embryos displayed a significant decrease in Cdx2 concentration (control mean of 72.4 and LDN193189 mean of 52.8,
po0.001). Scale¼100 mm, SEM is reported.
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are differentially expressed zygotically, whereas the type II receptor
Bmpr2 is expressed exclusively in outside cells (Wicher et al.,
personal communication). BMP ligands are also known to bind to
other ALK family receptors to activate Smad1/5/8 signaling (Roelen
et al., 1997; Maserbourg et al., 2005). Based on these expression
data, we hypothesize that BMP signaling inputs for ICM and TE cells
are mediated via utilization of different BMP ligands and receptors,
and thus transcriptional machinery. This model is consistent with
our observations indicating the presence of BMP signaling in both
ICM and TE cells, but displaying differential transcriptional response
toward BRE-reporter gene in ICM and TE cells (Fig. 1). The differ-
ential response of ICM and TE cells toward BMP signaling is likely to
depend on the utilization of different transcription factors present
in ICM and TE cells, which are expected to partner with Smad1/4
differentially.
These instances of qualitatively different BMP signaling during
blastocyst formation may not be apparent by examination of p-Smad1
immunostaining, as p-Smad1 staining represents a general readout of
overall canonical BMP signaling activity and this approach is unable to
distinguish different pathways of BMP signaling. Specifically, different
sets of targets can be modulated at different developmental time in
different tissues, dependent on the availability of different Smad part-
ners and receptors. It will be important to better define the spatio-
temporal expression patterns of various BMP signaling components
within the embryo in order to elucidate the roles these components
play during preimplantation stage mouse development, a crucial step
in the reconciliation and incorporation of BMP signaling pathway data
into the current gene regulatory network addressing blastocyst form-
ation in the mouse.
Experimental procedures
Detailed description of materials and methods are described in
supplemental information
Embryo acquisition and in vitro culture
Preimplantation stage mouse embryos were collected at
desired embryonic day by flushing uterine horns or oviducts with
Dulbecco’s Modified Eagle Medium (DMEM) with Hepes (10 mM,
pH 7.3) media. Embryos were rinsed in flushing and holding media
three times before culturing in vitro in micro-droplets containing
KSOMaa (Life Technologies) and solvent control-DMSO (Sigma
Aldrich), which were layered with light mineral oil (Sigma Aldrich)
When necessary, LDN193189 (Stemgent) or Noggin (R&D Systems)
were included in KSOMaa micro-droplets. Mouse embryos were
staged according Gardner (1997).
ES cell culturing, cell transfection, and Western blot
Mouse E14Tg2a ES cells were maintained in GMEM medium
(Sigma Aldrich) with 10% FBS (Hyclone) DNBR-HA and pCMV-β-gal
constructs were transfected into ES cells using Lipoectamine2000
(Invitrogen). For Western blot analysis, cells were homogenized in
RIPA buffer and subjected to gel electrophoresis. Primary anti-
bodies (see Table S2) were anti-p-Smad1 (1:500, Millipore), anti-
Smad (1:200, Santa Cruz Biotechnology), anti-HA (1:200, Santa
Cruz biotechnology), or anti-Tubulin (1:10,000, Life Technologies).
Quantitative polymerase chain reaction (qPCR)
RNAs were isolated after treatment of E14Tg2a mES cells with
hBMP4 (R&D Systems) or LDN193189 (Stemgent) using Trizol
(Life Technologies). Reverse transcription was performed using
MMLV Reverse Transcriptase according to manufacturer’s guide-
line. Quantitative PCR reactions were performed using Sybr-Green
(Roche) and the primers listed in Supplemental Materials and
methods.
X-gal and immunofluorescence staining
For X-gal staining, E14Tg2a cells were rinsed in pre-warmed
PBS, fixed in 0.05% glutaraldehyde at room temperature for 15
minutes and incubated in X-gal (10 mg/ml) at 37 1C. Preimplanta-
tion stage mouse embryos were fixed in 4% paraformaldehyde,
washed, and incubated with X-gal overnight.
For immunostaining, E14Tg2a mES cells were fixed with 3.7%
formaldehyde in 1X PBS, rinsed with 1X PBS, and incubated in
permeabilization buffer (0.24% Triton-X100) for 15 min at room
temperature. After pre-incubation with blocking solution, the
cells were incubated with indicated primary antibodies, anti-p-
Smad1/5/8 (1:100, Millipore) or anti-SMAD1/5/8 (1:200, Santa
Cruz Biotechnology) overnight. Secondary antibodies were goat
anti-rabbit-Alexa555 (1:200, Life Technologies) and donkey anti-
mouse Cruz647 (1:200, Santa Cruz Biotechnology). Preimplanta-
tion stage mouse embryos were rinsed in Acid Tyrode’s solution,
(Sigma Aldrich), followed by a 30 min fixation with 3.7% formal-
dehyde. Primary antibodies used (see Table S2) were anti-p-
Smad1/5/8 (1:50 & 1:100, Millipore), anti-Smad1/5/8 (1:200, Santa
Cruz Biotechnology), anti-Cdx2 (1:200, BioGenex), and anti-Nanog
(1:200, Cosmo Bio USA). Additionally, E14Tg2a mES cells and
embryos were stained with Hoechst (2 mg/ml, Sigma Aldrich) and
Phalloidin-488 (1:40 dilution, Life Technologies) for nuclear and
F-actin staining, respectively. Embryos were placed on a glass slide
coated with a 1% agarose pad and compressed to a 3:1 aspect ratio.
All confocal images were acquired using a 200.8 NA (mES cells)
and 631.4 NA (embryos) objective, on an Axioobserver Z1 Zeiss
780 confocal microscope with Zen2009 software. Z-stack images
were acquired at 0.3 μm intervals.
Live imaging
Live imaging of H2BeGFP embryos was performed as previously
described (Kurotaki et al., 2007). A Leica microscope equipped
with Hamamatsu 1K EM-CCD was used.
Fluorescence quantification via image segmentation
We generated segmentation masks for individual nuclei in
fluorescence microscopy images of the early mouse embryo. First,
we manually annotated cell centers based on DNA images. Cell
labels (such as inside/outside/ICM/trophectoderm) were manually
assigned at this stage. Second, we preprocessed the DNA image for
segmentation by normalizing, blurring, and inverting the image.
Third, we generated segmentation masks by running active con-
tours initialized from the annotated cell centers (De Solorzano
et al., 2001). Expansion of active contour boundaries was con-
strained by areas of low intensity in the original DNA image and by
collisions with neighbors. A sample segmentation is given in
Fig. 2A. Lastly, we quantified p-Smad1/Nanog/Cdx2 concentration
by computing the average pixel intensity in individual nuclear
segmentation masks.
Embryos in each experiment were imaged in the same session;
this enabled direct comparison of fluorescence contents across
embryos in the same experiment. In order to verify accuracy of our
segmentation procedure, we compared fluorescence contents
derived from our procedure versus manual segmentations (gener-
ated using the Fiji Segmentation Editor; Schindelin et al., 2012)
and found close agreement (R2 of 0.98–0.94, Fig. S3A). In order to
minimize the impact of fluorescence attenuation along the z-axis
of the image, we only used “top layer” nuclei in subsequent
analysis (nuclei whose projection to the top of the stack was at
least 10% free of overlap with nuclei closer to the top of the stack):
fluorescence from “top layer” nuclei is minimally attenuated since
there is a minimal amount of tissue to traverse. In addition, mitotic
and polar body cells were annotated based on DNA morphology
and excluded from subsequent analysis.
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Above, we assay fluorescence levels via concentration (i.e.,
average pixel intensity). An alternative method of assaying fluor-
escence levels is to compute total content (i.e., summed pixel
intensities). In 64-cell stage embryos, significant differences in
p-Smad1 levels exist in ICM/TE cells when measured via total
content. However, these differences are relatively small (7%)
compared to results derived p-Smad1 concentrations (27%, Table
S1). We speculate that nuclear p-Smad1 concentration may be
a better readout of BMP signaling than total nuclear p-Smad1
content.
Data analysis
All p-values were computed using Student’s t-test (R studio,
Matlab). Images were visualized using ImageJ (NIH http://imagej.
nih.gov/ij/).
Dominant negative BMP receptor 1a expression construct and DNA
microinjections
Bmpr1aCA-pCIG pRosa26-DEST (gift from Edwin Monuki, Lim
et al., 2004) was used to generate DNA encoding a dominant
negative BMP receptor (DNBR-HA), which was sub-cloned into
pCS2þHA. Subsequently, the DNBR-HA was subcloned into pCMV-
β (MacGregor and Caskey, 1989). The human cytomegalovirus
(CMV) immediate early promoter (IEP), a splice acceptor–donor
region, precedes the DNBR-HA sequence. Lastly, an oligo adapter
with the P2A sequence was subcloned into pCS2-mCherry. The
P2A-mCherry fragment was cloned into the pCMV-DNBR-HA
vector to complete the construct that expresses both DNBR-HA
and mCherry under transcriptional control of the CMV IEP. C57BL/
6NTac 3-week old females were superovulated and embryos were
harvested at the 2-cell stage (embryonic day e1.5) (Nagy et al.,
2003). DNA fragments were gel purified, passed through a 0.22 μm
filter and injected into a single blastomere of 2-cell stage embryos
at a final concentration of 1.5 ng/μl total DNA. After microinjection,
embryos were washed four times and transferred in KSOMaa
media and incubated at 37 1C under hypoxic conditions (90% N2,
5% CO2, 5% O2) in 25 ml microdrops of pre-equilibrated media in a
Planer BT37 (Planer PLC, Sunbury-On-Thames, England) until the
required developmental stage was reached. Images were collected
using Olympus DP70.
Acknowledgements
We thank the Transgenic Mouse Facility at University of California,
Irvine for blastomere injections, Dr. Amanda Cinquin for advice on
confocal microscopy and immunostaining, Dr. Magdalena Zernicka-
Goetz for sharing unpublished data, and Dr. Ed Monuki for p-Smad1
antibody and pCIG-DNBR. We thank Dr. Ira Blitz for his intellectual
and editorial input, Dr. Hiroshi Sasaki for discussion, and Ms. Krishna
Patel for immunohistology and genotyping. This work was funded by
NIH (R01-HD056219 to KC and R01-GM102635 to OC, F31-HD074409
and R25GM055246 for NM, and T32-HD060555 and T15-LM007443
for MC). Additionally, research reported in this publication was
supported by the National Cancer Institute of the National Institutes
of Health under Award Number P30CA062203. The content is solely
the responsibility of the authors and does not necessarily represent
the official views of the National Institutes of Health.
Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2014.10.001.
References
Alexander, C., Zuniga, E., Blitz, I.L., Wada, N., LePabic, P., Javidan, Y., Zhang, T.,
Cho, K.W.Y., Crump, J.G., Schilling, T., 2011. Combinatorial roles for Bmps and
Endothelin1 in patterning the dorsal–ventral axis of the craniofacial skeleton.
Development 138, 5135–5146.
Arnold, S.J., Maretto, S., Islam, A., Bikoff, E.K., Robertson, E.J., 2006. Dose-dependent
Smad1, Smad5, and Smad8 signaling in the early mouse embryo. Dev. Biol. 296
(1), 104–118.
Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., Lovell-Badge, R., 2003.
Multipotent cell lineages in early mouse development depend on SOX2
function. Genes Dev. 17, 126–140.
Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A., Minowa, O., Noda, T., Miyazono,
K., 2000. BMP Type II receptor is required for gastrulation and early develop-
ment of mouse embryos. Dev. Biol. 221, 249–258.
Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., Smith, A.,
2003. Functional expression cloning of Nanog, a pluripotency sustaining factor
in embryonic stem cells. Cell 113, 643–655.
Chu, G.C., Dunn, N.R., Anderson, D.C., Oxburgh, L., Robertson, E.J., 2004. Differential
requirements for Smad4 in TGFbeta-dependent patterning of the early mouse
embryo. Development 131 (15), 3501–3512.
Ciemerych, M., Sicinski, P., 2005. Cell cycle in mouse development. Oncogene 24,
2877–2898.
Copp, A.J., 1978. Interaction between inner cell mass and trophectoderm of mouse
blastocyst. I. A study of cellular proliferation. J. Embryol. Exper. Morpho 48,
109–125.
Coucouvanis, E., Martin, G.R., 1999. BMP signaling plays a role in visceral endoderm
differentiation and cavitation in the early mouse embryo. Development 126,
535–546.
Cuny, G.D., Yu, P.B., Laha, J.K., Xing, X., Liu, J.F., Lai, C.S., Deng, D.Y., Sachidanandan, C.,
Bloch, K.D., Peterson, R.T., 2008. Structure-activity relationship study of bone
morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18,
4388–4392.
Derynck, R., Zhang, Y.E., 2003. Smad-dependent and Smad-independent pathways
in TGF-beta family signaling. Nat. 425, 577–584.
De Solorzano, C.O., Malladi, R., Lelièvre, S.A., Lockett, S.J., 2001. Segmentation of
nuclei and cells using membrane related protein markers. J. Microsc. 201 (Pt 3),
404–415.
Dietrich, J.E., Hiiragi, T., 2007. Stochastic patterning in the mouse pre-implantation
embryo. Development 134, 4219–4231.
Doan, L., Javier, A., Cho, K.W.Y., Monuki, E., 2012. A Bmp reporter with ultrasensitive
characteristics reveals that high Bmp signaling is not required for cortical hem
fate. PLoS One 7 (9), e44009.
Eom, D.S., Amarnath, S., Fogel, J.L., Agarwala, S., 2011. Bone morphogenetic proteins
regulate neural tube closure by interacting with the apicobasal polarity path-
way. Development 138, 3179–3188.
Fuentealba, L.C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E.M., De Robertis,
E.M., 2007. Integrating patterning signals: wnt/gsk3 regulates the duration of
the BMP/Smad1 signal. Cell 131 (5), 980–993.
Gardner, R.L., 1997. The early blastocyst is bilaterally symmetrical and its axis of
symmetry is aligned with the animal–vegetal axis of the zygote in the mouse.
Development 124 (2), 289–301.
Gardner, R.L., Davies, T.J., 2002. Trophectoderm growth and bilateral symmetry of
the blastocyst in the mouse. Hum. Reproduct. 17 (7), 1839–1845.
Guo, G., Huss, M., Tong, G.Q., Wang, C., Sun, L.L., Clarke, N.D., Robson, P., 2010.
Resolution of cell fate decisions revealed by single-cell gene expression analysis
from zygote to blastocyst. Dev. Cell 18, 675–688.
Hogg, K., Etherington, S.L., Young, J.M., McNeilly, A.S., Duncan, W.C., 2010. Inhibitor
of differentiation (ID) genes are expressed in the steriodogenic cells of the
ovine ovary and are differentially regulated by members of the transforming
growth factor-b family. Endocrinology 151 (3), 1247–1256.
Hollnagel, A., Oehlmann, V., Heymer, J., Ruther, U., Nordheim, A., 1999. Id genes are
direct targets of bone morphogenetic protein induction in embryonic stem
cells. J. Biol. Chem. 274 (28), 19838–19845.
Javier, A., Doan, L., Luong, M., Reyes de Mochel, N.S., Blitz, I.L., Monuki, E., Cho, K.W.Y.,
2012. Dynamically regulated expression patterns of BMP signaling using BRE-gal
indicator mice. PLoS One 7, e42566.
Komatsu, Y., Kaartinen, V., Mishina, Y., 2011. Cell cycle arrest in node cells governs
cilliogenesis at the node to break left-right symmetry. Development 138 (18),
3915–3920.
Kretzschmar, M., Doody, J., Massague, J., 1997. Opposing BMP and EGF signaling
pathways converge on the TGF-beta family mediator Smad1. Nature 389
(6651), 618–622.
Kurotaki, Y., Hatta, K., Nakao, K., Nabeshima, Y., Fujimori, T., 2007. Blastocysts axis is
specified independently of early cell lineage but aligns with the ZP shape.
Science 316, 719–723.
Lim, Y., Cho, G., Minarcik, J., Golden, J., 2004. Altered BMP signaling disrupts chick
diencephalic development. Mech. Dev. 122, 603–620.
MacGregor, G.R., Caskey, C.T., 1989. Constrution of plasmids that express E. coli
beta-galactosidase in mammalian cells. Nucleic. Acids Res. 17, 2365.
Macías-Silva, M., Hoodless, P.A., Tang, S.J., Buchwald, M., Wrana, J.L., 1998. Specific
activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
J. Biol. Chem. 273 (40), 25628–25636.
Maretto, S., Cordenonsi, M., Dupont, S., Braghetta, P., Broccoli, V., Hassan, A.B.,
Volpin, D., Bressan, G.M., Piccolo, S., 2003. Mapping Wnt/beta-catenin signaling
N.S. Reyes de Mochel et al. / Developmental Biology 397 (2015) 45–5554
during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci.
U.S.A. 100, 3299–3304.
Martin, R.M., Leonhardt, H., Cardoso, M.C., 2005. DNA labeling in living cells.
Cytomerty Part A 67A, 45–52.
Maserbourg, S., Snagkuhl, K., Luo, C.W., Sudo, S., Klein, C., Hsueh, A.J.W., 2005.
Identification of receptors and signaling pathways for orphan bone morpho-
genetic protein/growth differentiation factor ligands based on genomic analy-
sis. J. Biol. Chem. 280, 32122–32132.
Massari, M.E., Murre, C., 2000. Helix–loop–helix proteins: regulators of transcrip-
tion in eukaryotic organisms. Mol. Cell Biol. 20, 429–440.
Mishina, Y., Suzuki, A., Ueno, N., Behringer, R.R., 1995. Bmpr encodes a type I bone
morphogenetic protein receptor that is essential for gastrulation during mouse
embryogenesis. Genes Dev. 9, 3027–3037.
Moustakas, A., Heldin, C.H., 2005. Non-Smad TGF-beta signals. J. Cell Sci. 118 (16),
3573–3584.
Murre, C., McCaw, P.S., Vaessin, H., Caudy, M., Jan, L.Y., Jan, Y.N., Cabrera, C.V.,
Buskin, J.N., Hauschka, S.D., Lassar, A.B., Weintraub, H., Baltimore, D., 1989.
Interactions between heterologous helix–loop–helix proteins generate com-
plexes that bind specifically to a common DNA sequence. Cell 58, 537–544.
Nagy, A., Gertsenstein, M., Vintersten, K., Behringer, R., 2003. Manipulating the
Mouse Embryo. Cold Spring Harbor Press, New York (Cold Spring Harbor).
Natale, D.R., Paliga, A.J.M., Beier, F., D'Souza, S.J.A., Watson, A.J., 2004. 38 MAPK
signaling during marine preimplantation development. Dev. Biol. 268, 76–88.
Nichols, J., Sevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I.,
Scholer, H., Smith, A., 1998. Formation of pluripotent stem cells in the
mammalian embryo depends on the POU transcription factor Oct4. Cell 95
(3), 37–91.
Nishioka, N., Yamamoto, S., Kiyonari, H., Sato, H., Sawada, A., Ota, M., Nakao, K.,
Sasaki, H., 2008. Tead4 is required for specification of trophectoderm in pre-
implantation mouse embryos. Mech. Dev. 125 (3-4), 270–283.
Roelen, B.A.J., Goumans, M.J., Van Rooijen, M.A., Mummery, C.L., 1997. Differential
expression of BMP receptors in early mouse development. Int. J. Dev. Biol. 41,
541–549.
Rossant, J., Tam, P.P.L., 2009. Blastocyst lineage formation, early embryonic
asymmetries and axis patterning in the mouse. Development 136, 701–713.
Sapkota, G., Alarcon, C., Spagnoli, F.M., Brivanlou, A.H., Massague, J., 2007. Balancing
BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25,
441–454.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaying, V., Longair, M., Pietzsch, T.,
Preilbisch, S., Rueden, C., Saafeld, S., Schmid, B., Tinevez, J.Y., White, D.J.,
Hartenstein, V., Ellceiri, K., Tomancak, P., Cardona, A., 2012. Fiji: an open-
source platform for biological image analysis. Nat. Methods 9, 676–682.
Smith, R., McLaren, A., 1977. Factors affecting the time of formation of the mouse
blastocoel. J. Embryol. Exp. Morph. 41, 79–92.
Solloway, M.J., Robertson, E.J., 1999. Early embryonic lethality in Bmp5;Bmp7
double mutant mice suggests functional redundancy within the 60A subgroup.
Development 126, 1753–1768.
Strumpf, D., Mao, C.A., Yamanaka, Y., Ralston, A., Chawengsaksophak, K., Beck, F.,
Rossant, J., 2005. Cdx2 is required for correct cell fate specification and
differentiation of trophectoderm in the mouse blastocyst. Development 132,
2093–2102.
Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M.F., Taketo, M.M., 1998.
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and
Apc genes. Cell 92, 645–656.
Tang, F., Barbacioru, C., Bao, S., Lee, C., Nordman, E., Wang, X., Lao, K., Surani, A.,
2010. Tracing the derivation of embryonic stem cells from the inner cell mass
by single-cell RNA-Seq analysis. Cell Stem Cell 6, 468–478.
Vogt, J., Traynor, R., Sapkota, G.P., 2011. The specificities of small molecule inhibitors
of the TGFß and BMP pathways. Cell Signal 23 (11), 1831–1842.
von Bubnoff, A., Peiffer, D., Blitz, A., HayataT., I.L., Ogata, S., Miyazono, K., Cho, K.W.Y.,
2005. Phylogenetic footprinting and genome scanning identifies vertebrate BMP
response elements and new target genes. Dev. Biol. 281, 210–226.
Wang, H., Dey, S.K., 2006. Roadmap to embryo implantation: clues from mouse
models. Nat. Rev. Genet. 3, 185–199.
Westermarck, S.P., Li, T., Kallunki, J., Han, J., Kahari, V.M., 2001. P38 mitogen-
activated protein kinase-dependent activation of protein phosphatases 1 and
2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expres-
sion. Mol. Cell Biol. 21 (7), 2373–2383.
White, E., 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1–15.
Yagi, R., Kohn, M.J., Karavanova, I., Kaneko, K.J., Vullhorst, D., DePamphilis, M.L.,
Buonanno, A., 2007. Transcription factor TEAD4 specifies the trophectoderm
lineage at the beginning of mammalian development. Development 134 (21),
3827–3836.
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T.,
Nishida, E., Matsumoto, K., 1995. Identification of a member of the MAPKKK
family as a potential mediator of TGF-beta signal transduction. Science 270
(5244), 2008–2011.
Yamaguchi, K., Nagai, S., Ninomiya-Tsuji, J., Nishita, M., Tamai, K., Irie, K., Ueno, N.,
Nishida, E., Shibuya, h., Matsumoto, K., 1999. XIAP, a cellular member of the
inhibitor of apoptosis protein family, links the receptors of Table1-TAK1 in the
BMP signaling pathway. EMBO J. 18 (1), 179–187.
Yao, L.C., Blitz, I.L., Peiffer, D.A., Phin, S., Wang, Y., Ogata, S., Cho, K.W.Y., Arora, K.,
Warrior, R., 2006. Transcription factors mediate a phylogenetically conserved
nuclear response to BMP signaling. Development 133, 4025–4034.
Yi, S.E., Daluiski, A., Pederson, R., Rosen, V., Lyons, K.M., 2009. The type I BMP
receptor BMPRIB is required for chondrogenesis in the mouse limb. Develop-
ment 127 (3), 621–630.
Ying, Q.L., Nichols, J., Chambers, I., Smith, A., 2003. BMP induction of Id proteins
suppresses differentiation and sustains embryonic stem cell self-renewal in
collaboration with STAT3. Cell 115 (3), 281–292.
Yu, Y.B., Hong, C.C., Sachidanandan, C., Babitt, J.L., Deng, D.Y., Hoyng, S.A., Lin, H.Y.,
Bloch, K.D., Peterson, R.T., 2008. Dorsomorphin inhibits BMP signals required
for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33–41.
Zernicka-Goetz, M., Morris, S.A., Bruce, A.W., 2009. Making a firm decision:
multifaceted regulation of cell fate in the early mouse embryo. Nat. Rev. Genet.
10, 467–477.
Ziomek, C.A., Johnson, M.H., Handyside, A.H., 1982. The developmental potential of
mouse 16-cell blastomeres. J. Exp. Zool. 221, 345–355.
N.S. Reyes de Mochel et al. / Developmental Biology 397 (2015) 45–55 55






Supplemental Figure Legends 
 
Figure S1: RPKM analysis of single cell RNA-seq data.  
Varying amount of transcripts encoding the indicated BMP ligands and receptors 
are present in 2-cell, 4-cell, 8-cell stage embryos.  ICM and trophectoderm cells 
of blastocysts express some common and different BMP ligands and receptors.  
 
Figure S2: LDN specifically inhibits BMP signaling in mouse mES cells, 
related to Figure 1  
A) Phosphorylated Smad1/5/8 is present in the nucleus following stimulation with 
BMP4 (20ng/ml) and significantly reduced when co-treated with BMP 
antagonists, Noggin (50ng/ml) or LDN193189 (80nM). DNA is in blue, pSmad1 in 
red. B) LDN193189 (80nM) and Noggin (50ng/ml) inhibit BRE-gal expression in 
mouse ES (mES) cells after BMP4 (20ng/ml) stimulation. C) Western blot of 
E14Tg2a mES cells treated with BMP4 (20ng/ml) in presence or absence of 
LDN193189 (80nM).  Phosphorylated Smad1 (p-Smad1) is detected upon BMP4 
stimulation (lane 4) and in the presence of LDN193189, Smad1 phosphorylation 
is inhibited (lane 5). D) qRT-PCR analysis of Id genes in mES cells cultured in 
the presence of BMP4 (BMP4 20ng/ml), LDN193189 (80nM), or both. 
 
 
Figure S3: Fluorescence intensity quantification of p-Smad1, related to 
Figure 2 
A) Correlations of pSmad1 (R2=0.98), Nanog (R2=0.95), and Cdx2 (R2=0.94) 
concentrations between automatic (y-axis) and manual (x-axis) segmentations. 
B) pSmad-1 concentration in three individual 4- and 8-cell stage embryos (left 
panel) and embryos at 16-, 32- and 64- cell stage (right panel). C) Distribution of 
nuclear pSmad1 concentrations in 3 16-cell embryos and 3 64-cell embryos 
(inside and ICM cells in red and outside and TE in blue). D) pSmad1 total nuclear 
content (computed as the sum of pixel intensities), pSmad1 content normalized 
by DNA content, and pSmad1 concentration in cells from 13 aggregated 64-cell 
embryos (ICM cells shown in red and TE cells in blue). A Student’s t-test was 
used to test whether different methods yielded significantly-different results (refer 
to supplement Table S1). Y-axis represents relative fluorescence from low to 
high (0 to 1).  
 
Figure S4: Effects of BMP signaling inhibition on apoptosis, related to 
Figure 3 
A) TUNEL assay on embryos treated with LDN193189 for 24 hours. No TUNEL 
positive cell is found in embryos treated with 0.25µM (n = 6), 0.5µM (n=12), 1µM 
(n=16) of LDN139189. At 2.5 µM LDN139189 (n=5), TUNEL-positive cells are 
detected. Note polar bodies are TUNEL-positive in control and other LDN193189 
treated embryos. DNA in blue, TUNEL positive cells in green. Scale bar = 
100µm. 
 
Figure S5: Reduced cell number in embryos cultured in LDN193189 for 12 
hours, related to Figure 4 
A) Total cell number is reduced in embryos cultured with LDN193189 for 12 
hours (LDN, n=14, 18.8±2.4 cells, control, n=10, 28±2.2 cells) and 24 hours 
(LDN, n=6, 29.6±2.2 cells, control, n=25, 56.2±3.5 cells). B) Average numbers of 
cells per embryo decreases in the presence of 0.25µM LDN193189 (32.5±2.0 
cells, n= 8). *p<0.05 and **p<0.001.  SEM is reported and a Student’s t-test was 
used to determine significance.  
 
Figure S6: Effects of pCMV-DNBR-HA and LDN193189 in mouse mES cells 
and embryos, related to Figure 5 
A) Western blot demonstrating an increase of phosphorylated Smad1 after BMP4 
(20ng/ml) stimulation. Smad1 phosphorylation is inhibited after DNBR-HA 
expression in E14Tg2a mES cells. B) HA-tagged DNBR is detected on the 
membrane of cells in 8-cell stage embryo derived from the blastomere injected at 
the 2-cell stage. C) pSmad1 concentration decreases in pCMVβ/DNBR-HA 
(mean 0.27, n= 10) when compared to injected control pCMVβ (mean of 0.35, 
n=6, p<0.001). D) Increase in the number of hours embryos cultured in 
LDN193189 took to reach the 16-cell stage from 2-cell stage (control 44 hours, 
(n=16), LDN 48 hours, (n=17)). *p<0.05 and **p<0.001.  SEM is reported and a 
Student’s t -test was used to determine significance. 
 
 
Table S1, Analysis of pSmad1 nuclear content, related to figure S3D 
Figure -Data! Total content! Normalized by 
DNA!
Normalized by 
Volume!
Figure 2D  
  
16-cell stage 
Not significant 
  
Inside (mean 
0.35) vs outside 
(mean 0.39)  
  
p>0.05 
11% difference 
Not significant 
  
Inside (mean 
0.39) vs outside 
(mean 0.42) 
  
p>0.05 
8% difference 
Not significant 
  
Inside (mean 
0.44) vs outside 
(mean 0.48) 
  
p>0.05 
9% difference 
Figure 2D  
  
32-cell stage 
Significant 
  
ICM (mean 0.32) 
vs TE (mean 
0.36) 
  
P<0.05 
12% difference 
Not significant 
  
ICM (mean 0.40) 
vs TE (mean 
0.43) 
  
P>0.05 
7% difference 
Not significant 
  
ICM (mean 0.49) 
vs TE (mean 
0.47) 
  
p>0.05 
4% difference 
Figure 2D  
  
64-cell stage 
Significant 
  
ICM (mean 0.30) 
vs TE (mean 
0.28) 
  
P<0.05 
7% difference 
Significant 
  
ICM (mean 0.41) 
vs TE (mean 
0.29)  
  
p<0.001 
30% difference 
Significant 
  
ICM (mean 0.52) 
vs TE (mean 
0.38) 
  
p<0.001 
27% difference 
Antibody! Dilution 
used!
Supplier! Catalog #! Lot #!
Rabbit anti-
pSmad1/5/8!
1:50, 
1;100, 
1:500!
Millipore! AB3848! 2390361!
Rabbit anti-
Smad1/5/8 (N-18)-R!
1:200! Santa Cruz 
Biotechnology Inc.!
SC-6031_R! A1613!
Rabbit anti-Oct3/4 
(C-10) !
1:250! Santa Cruz 
Biotechnology Inc.!
SC-5279! Not available!
Rabbit anti-nanog! 1:200! Cosmo Bio Co.! RCAB0002P-F!  20100713!
Mouse Anti-Cdx2! 1:200! BioGenex! MU392A-UC! MU392A0114X!
Goat anti-Sox17! 1:200! R&D! AF1924! KGA0613041!
Rabbit anti-HA 
(Y-110!
1:200! Santa Cruz 
Biotechnology Inc.!
SC-805! A1205!
Mouse anti-Tubulin! 1:10,000! Life Technologies! T5168-2ml! 051M4771!
Goat anti-rabbit 
(Alexa-555)!
1:200! Life Technologies! A21428! 1511349!
Donkey anti-rabbit 
(Alexa-555)!
1:200! Life Technologies! A31572! 1249018!
Goat anti- mouse 
IgG-CFL647!
1:200! Santa Cruz 
Biotechnology Inc.!
SC-362287! D3013!
Donkey anti- goat 
IgG-CFL647!
1:200! Santa Cruz 
Biotechnology Inc.!
SC-362285! B1313!
Table S2, Antibodies used for this study 
Table S1 Analysis of pSmad1 nuclear content, related to Figure S3D 
Table presenting pSmad1 total nuclear content (computed as the sum of pixel 
intensities), pSmad1 content normalized by DNA content, and pSmad1 
concentration for data on Figure 2c (16-, 32-, and 64-cell stage embryos). 
 
Table S2 Antibodies used for this study 
Table of antibodies used for this study which includes, dilutions used, supplier, 
catalog #, and lot # information. 
 
Supplemental Experimental Procedures 
 
Embryo acquisition 
Three-week old CD1 females (Charles River) were superovulated using pregnant 
mare serum (PMSG, Sigma Aldrich, catalog #G-4877, 2000IU/vial) followed ~ 45 
hours later by human chorionic gonadotropin (hCG, Sigma Aldrich, catalog #C-
1063, 2500IU/vial).  All females received 5 IU doses of each hormone 
intraperitoneally. After hCG (Sigma Aldrich, catalog #C-1063, 2500IU/vial) 
injections, mating were set up. Females were checked the following morning for 
mating plugs, at which they were considered e0.5 if a vaginal plug was present.  
Embryos were collected at desired embryonic day by flushing uterine horns or 
oviducts with Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, 
catalog #11965-092) with Hepes (10mM) media (Life Technologies, catalog 
#15630-106).   
 
In vitro culture 
Embryos were rinsed three times with DMEM (Life Technologies, catalog 
#11965-092) plus Hepes (Life Technologies, catalog #15630-106) and then 
prepared for in vitro culture in 35 µl microdroplets of KSOMaa (Life Technologies, 
catalog #MR-121-D) covered with a layer of light mineral oil (Sigma Aldrich, 
catalog #M5310-1L).  The microdroplets were equilibrated at 37°C with 5% CO2 
for 1 hour prior to addition of embryos. All dissected embryos were imaged using 
Olympus DP70. Embryos were incubated for 24 hours at 37°C, 5% CO2 in a 
humidified Sanyo incubator (Sanyo Scientific).   
 
mES cell culture 
E14Tg2a mouse ES cells were cultured on 0.1% gelatin-coated plates containing 
GMEM medium (Sigma Aldrich, #G5153) with 10% FBS (Hyclone, catalog 
#SH30071.03), 0.1mM NEAA, 1mM Sodium Pyruvate, 1000U/ml LIF (Millipore, 
catalog #ESG1107), and 0.1mM 2-Mercaptoethanol.  Cells were maintained at 
37°C, 5% CO2, and split using 0.25% trypsin (Life Technologies, catalog #15400-
054). 
 
mES cell transfection 
pCMV-DNBR-HA and pCMV-β vectors were transfected into E14Tg2a mES cells 
using Lipofectamine2000 (Invitrogen, catalog #11668027) according to 
manufacture’s protocol. Cells were collected for immunofluorescence or western 
blot analysis after 48 hrs post-transfection.  
 
BMP signaling inhibition assay 
LDN193189 (Stemgent, catalog #04-0074, lot#1861) was diluted in KSOMaa to a 
final concentration of 2.5µM, 1µM, 0.5µM, or 0.25µM from a 10mM stock 
(dissolved in DMSO, Sigma Aldrich, catalog #D2650). Embryos were placed in 
LDN193189/KSOMaa or Noggin/KSOMaa (R&D Sysems, catalog #1967-NG, 
lot#ETY08) microdroplets that had been pre-equilibrated for at least 1 hour. 
Noggin (R&D Sysems, catalog #1967-NG, lot#ETY08) was dissolved in 1X PBS 
for final concentration of (50µg/ml, 10µg/ml, and 1µg/ml). Control embryos were 
similarly placed in microdroplets containing DMSO (Sigma Aldrich, catalog 
#D2650) solvent.  
 
Immunofluorescence 
mES cells:  Cells were washed with 1X PBS (3x times), fixed with 3.7% 
formaldehyde for 15 minutes at room temperature (RT), rinsed with 1X PBS, and 
set in permeabilization buffer (0.25% Triton-X100 , Sigma Aldrich, catalog 
#107110934) for 15 minutes at RT. The cells were then blocked for 1 hour, and 
incubated in solution containing primary antibodies at 4°C overnight. Antibodies 
used were anti-pSMAD1,5,8 (1:100), anti-SMAD1,5 (1:200), and rabbit anti-Oct4 
(1:250). After incubation, cells were rinsed with 1x PBS-Tween-20 (Fisher, 
catalog #EC-500-018-3) (0.1%) (1xPBS-T) then incubated with goat anti-rabbit-
Alexa555 (1:200, Life Technologies) for 1 hour at room temperature. Additionally, 
cells were stained with Hoechst (2µg/ml, Sigma Aldrich, catalog #H21486) and 
Phalloidin-488 at 1:40 dilution (Life Technologies, catalog #A12379, 300U) for 
the nucleus and F-actin staining, respectively. All images were taken using Zeiss 
780 confocal with 20x 0.8 NA objective with Zen2009 software.   
 
Mouse embryos: Embryos were treated in Acid Tyrode solution for two minutes, 
rinsed in DMEM (Life Technologies, catalog #11965-092) plus Hepes (Life 
Technologies, catalog #15630-106), followed by a 30 minutes fixation with 3.7% 
formaldehyde in 0.95X PBS on ice.  Embryos were rinsed in 0.95X PBS and 
permeabilized for 15 minutes (0.2% TritonX-100 in 0.95X PBS) (Sigma Aldrich, 
catalog #107110934) before blocking for 1 hour at room temperature (0.2% BSA 
(Affymetrix, catalog #10868, lot#4135579), 0.2% TritonX-100, 2% goat, or 
donkey serum, in 0,95X PBS). All primary antibody incubations were performed 
at 4°C. Primary antibodies (see Table S2) were used at the following dilutions:  
anti-pSmad1,5,8 (1:50), anti-Smad1,5,8 (1:200), anti-Oct4 (1:250), anti-Sox17 
(1:200), anti-Cdx2 (1:200), and anti-Nanog (1:200). Additionally, embryos were 
stained with Hoechst (2µg/ml, Life Technologies, catalog #H21486) and 
Phalloidin-488 (1:40 dilution, Life Technologies, catalog #A12379, 300U). All 
embryo images were acquired using a Zeiss 780 confocal microscope on a Zeiss 
AxioImager Z1 stand using a 63x, 1.4NA objective with Zen2009 software.  Z-
stack images were acquired at 0.3µm intervals for high-resolution 3D rendering. 
 
Western Blotting 
Mouse ES cells were collected in RIPA buffer (150mM NaCl, 50mM Tris-HCl pH 
8.0, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 25mM β-
glycerophosphate, 100nM NaF, and 1mM Na3VO4) and 15µg of protein lysates 
were electrophoresed through a 12% PAGE-SDS gel. Primary antibodies (see 
Table S2) used were: anti-p-Smad1 (1:500), anti-Smad (1:200), anti-HA (1:200), 
anti-β-tubulin (1:10,000). ECL kit (GE Healthcare, catalog #RPN2232) was used 
for visualization.  
 
X-gal stain 
Embryos collected at the desired embryonic stages were fixed in 4% 
paraformaldehyde (PFA) in 1X PBS for 30 minutes on ice. Before incubating 
embryos overnight with X-gal (10µg/ml) in X-gal stain solution butter (2mM 
MgCl2, 5mM K ferrocyanide, 5mM K ferricyanide in 1X PBS) at 37°C, embryos 
were rinsed with Wash A (2mM MgCl2 and 5mM EGTA in 1X PBS), then in Wash 
B (2mM MgCl2, 0.01% sodium deoxycholate and 0.02% Nonidet P-40 1X PBS). 
ES cells were fixed in 0.05% glutaraldehyde solution and incubated in X-gal 
solution overnight 37°C. DNA of embryos and ES cells was stained with Hoechst 
(Life Technologies, catalog #H21486).    
 
Quantitative Polymerase Chain Reaction (qPCR) 
RNA was isolated after treatment of mES cells with 20ng/ml hBMP4 (R&D 
Systems, catalog #314-BP) or 80nM LDN193189 (Stemgent, Stemgent, catalog 
#04-0074, lot#1861) using Trizol (Life Technologies, catalog #15596-026). 
Reverse transcription was performed using MMLV Reverse Transcriptase 
(Invitrogen, catalog #28025-013) according to manufacture’s guideline. 
Quantitative PCR was performed using SYBR Green (Roche, catalog #04-707-
516-001). 
 
Dominant negative BMP receptor 1a (DNBR) construct 
To generate an epitope tagged DNBR, we used the Bmpr1aCA-pCIG pRosa26-
DEST construct (gift from Dr. Edwin Monuki, UCI) to PCR amplify the DNBR 
fragment containing ClaI (New England Bio Labs, catalog #R0197S) and NcoI 
ClaI (New England Bio Labs, catalog #R0193S) restriction sites at the 5’and 3’ 
ends, respectively. The amplicons were sub-cloned into pCS2+HA, generating 
epitope tagged pCS2+-DNBR-HA. An epitope tagged DNBR-HA fragment was 
subcloned into the HindIII (New England Bio Labs, catalog #R0104S) and HpaI 
(New England Bio Labs, catalog #R0105S) digested sites of pCMV-β after 
removing the LacZ gene. The resulting DNBR-HA gene resides downstream of 
the CMV immediate early promoter linked to splice acceptor/donor region. 
Primers for PCR amplification and sequencing are listed below. 
 
DNA microinjections 
All animal experimentation was conducted in accordance with federal guidelines 
for animal welfare with the studies being approved by the UCI Institutional Animal 
Care and Use Committee.  UCI’s Transgenic Mouse Facility (TMF) conducted all 
microinjection of mouse pre-implantation embryos. Briefly, C57BL/6NTac 3-week 
old females were superovulated using 5 IU of PMSG (Sigma Aldrich, catalog #G-
4877, 2000IU/vial) followed ~ 45 hours later by 5 IU of hCG (Sigma Aldrich, 
catalog #C-1063, 2500IU/vial) and mated to C57BL/6NTac stud males. Embryos 
were harvest at the 2-cell stage (embryonic day e1.5). DNA fragments (pCMV-β-
gal control and pCMV-DNBR-HA) were gel purified, filtered through 0.22µm 
filters, and injected at 1.5ng/µl concentration and 1ng/µl, respectively, into the 
cytoplasm of each blastomere. After microinjections, embryos were transferred in 
KSOMaa media, imaged, and cultured for 24 hours.  To control for DNA 
concentration injected, control embryos (pCMV-β only) were injected with the 
same total concentration of DNA injected into experimental embryos (DNBR-HA 
+ pCMVβ). 
 
Materials 
DNBR amplicons for DNBR-HA 
Forward: 5’-
TTTTATCGATGCGGCCGCCATGCCTCAGCTATACATTTACATCAGATTATTG
GG-3’ 
 
Reverse: 5’- CCCCCATGGCTGCTTCATCCTGTTCCAAATCACGATTGTAAC-3’ 
DNBR-HA into pCMV 
 
Forward: 5’- ACCTCCCCCTGAACCTGAAA-3’ 
 
Reverse: 5’-CGGTGGGAGGTCTATATAAGCAGAGCT-3’ 
 
Oligos for generating pCS2+_P2A_mcherry 
 
Forward: 5’-
CTGAAGCTTGGGCCCGGAAGCGGAGCTACTAACTTCAGCCTGCTGAAGCA
GGCTGGAGACGTGGAGGAGACCCTGGACCTGCGGATCCCTG-3’ 
 
Reverse: 5’-
CAGGGATCCGCAGGTCCAGGGTTCTCCTCCACGTCTCCAGCCTGCTTCAGC
AGGCTGAAGTTAGTAGCTCCGCTTCCGGGCCCAAGCTTCAG-3’ 
 
qPCR primer sequences for Id genes: 
Id1 
Forward: 5’- GACATGAACGGCTGCTACTCAC -3’ 
Reverse: 5’- GACTTCAGACTCCGAGTTCAGC -3’ 
Id2 
Forward: 5’- GTGAGGTCCGTTAGGAAAAACAG -3’ 
Reverse: 5’- GTCGTTCATGTTGTAGAGCAGACT -3’ 
Id3 
Forward: 5’- CTGTCGGAACGTAGCCTGG -3’ 
Reverse: 5’- GTGGTTCATGTCGTCCAAGAG -3’ 
 
 
 
 
 
 
 
 
 
